Home > Annual Financials > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS Financial Statement Analysis
[BOM: 500420|NSE : TORNTPHARM]

The Revenues of TORRENT PHARMACEUTICALS have increased by 11.51% YoY .
The Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS has increased by 15.39 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

TORRENT PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 500420|NSE : TORNTPHARM]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹10,728 Cr₹9,620 Cr₹8,508 Cr₹8,005 Cr₹7,939 Cr
Expenses ₹7,364 Cr₹6,796 Cr₹6,077 Cr₹5,524 Cr₹5,769 Cr
Operating Profit (Excl OI) ₹3,364 Cr₹2,824 Cr₹2,431 Cr₹2,480 Cr₹2,170 Cr
Other Income ₹62 Cr₹63 Cr₹197 Cr₹57 Cr₹121 Cr
Interest ₹354 Cr₹333 Cr₹255 Cr₹353 Cr₹451 Cr
Depreciation ₹808 Cr₹707 Cr₹662 Cr₹658 Cr₹654 Cr
Profit Before Tax ₹2,352 Cr₹1,847 Cr₹1,226 Cr₹1,526 Cr₹1,187 Cr
Profit After Tax ₹1,656 Cr₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr
Consolidated Net Profit ₹1,656 Cr₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr
Earnings Per Share (Rs)₹56.47₹48.94₹36.79₹45.92₹73.97
PAT Margin (%)11.349.927.635.118.41
ROE(%)26.4625.3820.5013.1823.49
ROCE(%)27.3224.2820.3214.3517.62
Total Debt/Equity(x)0.400.570.850.680.83

Key Financials

Market Cap : ₹ 112,117.0 Cr
Revenue (TTM) : ₹ 11,516.0 Cr
Net Profit(TTM) : ₹ 1,911.0 Cr
EPS (TTM) : ₹ 56.5
P/E (TTM) : 58.7

Industry Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS -1.1% 1.6% 13.7%
SUN PHARMACEUTICAL INDUSTRIES -0.4% -0.9% 4.8%
DIVIS LABORATORIES -0.7% 1.6% 50.2%
CIPLA -1.7% -1.1% -2.3%
DR REDDYS LABORATORIES -4.3% -8% -4.4%
MANKIND PHARMA 6.8% 8% 20.9%
ZYDUS LIFESCIENCES -1.9% 0.1% -16.5%
LUPIN -4.3% -6.4% 4.6%
AUROBINDO PHARMA -5.1% -2.7% -15.3%


TORRENT PHARMACEUTICALS Revenues
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

11.51 %

5 Yr CAGR

7.82 %

Years Revenues % Change
Mar2025 ₹10,728 Cr
11.51
Mar2024 ₹9,620 Cr
13.07
Mar2023 ₹8,508 Cr
6.29
Mar2022 ₹8,005 Cr
0.82
Mar2021 ₹7,939 Cr -


TORRENT PHARMACEUTICALS Operating Profit
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

19.11 %

5 Yr CAGR

11.58 %

Years Operating Profit % Change
Mar2025 ₹3,364 Cr
19.11
Mar2024 ₹2,824 Cr
16.15
Mar2023 ₹2,431 Cr
-1.97
Mar2022 ₹2,480 Cr
14.27
Mar2021 ₹2,170 Cr -

Operating Margins
Y-o-Y

6.81 %

5 Yr CAGR

3.48 %

Years Operating Margin% % Change
Mar2025 31.35%
6.81
Mar2024 29.35%
2.69
Mar2023 28.58%
-7.75
Mar2022 30.98%
13.31
Mar2021 27.34% -

TORRENT PHARMACEUTICALS Profit After Tax
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

33.02 %

5 Yr CAGR

12.76 %

Years Profit After Tax % Change
Mar2025 ₹1,656 Cr
33.02
Mar2024 ₹1,245 Cr
60.22
Mar2023 ₹777 Cr
-37.92
Mar2022 ₹1,252 Cr
22.17
Mar2021 ₹1,025 Cr -

PAT Margins
Y-o-Y

14.31 %

5 Yr CAGR

7.76 %

Years PAT Margin(%) % Change
Mar2025 11.34 %
14.31
Mar2024 9.92 %
30.01
Mar2023 7.63 %
49.32
Mar2022 5.11 %
-39.24
Mar2021 8.41 % -

TORRENT PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

15.39 %

5 Yr CAGR

-6.53 %

Years EPS % Change
Mar2025 ₹56
15.39
Mar2024 ₹49
33.03
Mar2023 ₹37
-19.88
Mar2022 ₹46
-37.92
Mar2021 ₹74 -

TORRENT PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 500420|NSE : TORNTPHARM]

Y-o-Y

12.52 %

5 Yr CAGR

11.59 %

Years ROCE % Change
Mar2025 27.32%
12.52
Mar2024 24.28%
19.49
Mar2023 20.32%
41.60
Mar2022 14.35%
-18.56
Mar2021 17.62% -

TORRENT PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹3,313.2
Current MarketCap: ₹ 112,117.0 Cr
Updated EOD on :Jul 11,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-1.1%

1.6%

13.7%

SENSEX

-1.1%

-0%

3.2%

TORRENT PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE LARGEMIDCAP 4.5% 7.2% 8.3%
BSE 500 SHARIAH 4.3% 4.3% 1.1%
BSE MIDCAP -1.1% -0.5% -2.3%
NSE Indices1W1M1Y
NIFTY 500 EQUAL WEIGHT -0.7% -0.3% -0.3%
NIFTY PHARMA -0.7% 0.8% 9.4%
NIFTY ALPHA QUALITY LOW-VOLATILITY 30 -0.9% -0.5% -6.7%
NIFTY NEXT 50 -0.9% -1.2% -7.5%
NIFTY100 LOW VOLATILITY 30 -1% 0.8% 3.9%

You may also like the below Video Courses


FAQ about TORRENT PHARMACEUTICALS Financials


How the annual revenues of TORRENT PHARMACEUTICALS have changed ?

The Revenues of TORRENT PHARMACEUTICALS have increased by 11.51% YoY .

How the Earnings per Share (EPS) of TORRENT PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS has increased by 15.39 % YoY .